Kindred Biosciences, Inc. EBITDA Margin 2014-2021 | KIN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Kindred Biosciences, Inc. (KIN) over the last 10 years. The current EBITDA margin for Kindred Biosciences, Inc. as of June 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-06-30 | $0.01B | $-0.03B | -425.00% |
| 2021-03-31 | $0.04B | $-0.00B | -2.27% |
| 2020-12-31 | $0.04B | $-0.01B | -32.56% |
| 2020-09-30 | $0.04B | $-0.02B | -46.51% |
| 2020-06-30 | $0.04B | $-0.03B | -58.14% |
| 2020-03-31 | $0.00B | $-0.07B | -1625.00% |
| 2019-12-31 | $0.00B | $-0.06B | -1500.00% |
| 2019-09-30 | $0.00B | $-0.06B | -1525.00% |
| 2019-06-30 | $0.00B | $-0.06B | -1475.00% |
